Novartis Taiwan is working with NHIA, medical societies, and healthcare partners to strengthen ASCVD prevention and care through clearer clinical pathways, earlier follow-up, and more consistent cholesterol management. The initiative reflects Taiwan’s growing focus on practical, cross-sector approaches to chronic disease management under the Healthy Taiwan vision.
Novo Nordisk Taiwan is reframing obesity from weight loss to long-term health, emphasizing prevention, early intervention, and collaboration across Taiwan’s healthcare system. Through awareness, screening, and employee support, the company is helping advance a broader approach to metabolic health.
AmCham Taiwan’s Energy Committee cautions that recent solar law amendments may increase uncertainty, raise renewable energy costs, and strain investor confidence as electricity demand rises. The committee urges clearer implementation and greater policy continuity to protect Taiwan’s energy transition and competitiveness.
As Taiwan advances its Healthy Taiwan vision, experts from government, academia, and industry underscored that sustained investment in vaccination is essential to protecting vulnerable populations and strengthening long-term healthcare resilience.
Chang Gung Memorial Hospital is redefining healthcare in Taiwan through AI-driven innovation, sustainable practices, and global collaboration. By integrating research, technology, and social responsibility, it aims to build a smarter, greener, and more inclusive healthcare system for future generations.
Celebrating 30 years, Taiwan’s National Health Insurance is hailed globally for health equity and access—but rising costs and delayed drug access now pose serious sustainability challenges.
Under new leadership, Bayer Taiwan is strengthening its role as a bridge between advanced healthcare and sustainable food systems—fostering local partnerships, clinical trials, and regenerative farming to build a healthier future.
With groundbreaking therapies and deep collaboration across Taiwan’s healthcare system, Novartis Taiwan is driving innovation, advancing equity, and building a healthier future.
As Taiwan nears super-aged status in 2025, experts stress the urgency of early Alzheimer’s detection, advanced screening, and proactive care to ease societal burdens.
Eli Lilly, a global leader in healthcare innovation, is tackling Taiwan’s healthcare challenges under the leadership of new general manager Lauren Lazowski. Through advanced clinical trials, precision medicine, and strong partnerships, Lilly Taiwan is committed to improving patient outcomes and strengthening the healthcare system.
